Donald Trump vs Big Pharma: How medicines could become cheaper for Americans who struggle with healthcare spends

President Trump's "most favored nation" policy aims to drastically lower U.S. prescription drug prices by aligning them with the lowest international rates, impacting global pharmaceutical markets and sparking debate over innovation funding. The initiative, welcomed by many seeking affordable medication, faces challenges from industry influence and concerns about reduced R&D investment. This move represents a significant shift in healthcare policy.

Most Recent